We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Polarean Imaging Plc | LSE:POLX | London | Ordinary Share | GB00BF3DT583 | ORD GBP0.00037 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.10 | -2.67% | 3.65 | 3.50 | 3.80 | 3.75 | 3.65 | 3.75 | 52,736 | 08:45:57 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Surgical,med Instr,apparatus | 1.03M | -13.91M | -0.0644 | -0.58 | 8.09M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/4/2024 11:30 | Funded to Oct 2024. Assured finance in place and detailed. European market partner incoming . Deals pending. But wait nigel knows more or can't read | moontheloon | |
10/4/2024 11:24 | It's burning c.$800k a month with very little revenue. That is unsustainable. | nigelpm | |
10/4/2024 11:19 | Something big due you either miss it or you get it. Just do your own deep research | moontheloon | |
10/4/2024 11:18 | Well fda approval it went down work that out . Codes went down. Undervalued. Be a good scenario for current buyers | moontheloon | |
10/4/2024 10:48 | We've been close to all sorts of things here for years - guess what - none of it to date has added any value to the business | nigelpm | |
10/4/2024 10:34 | Yawn. Duke is being financed as we speak. Don't let the depressed share price caused by the amati departure cloud your judgment. If you don't like them leave. Go elsewhere ffs | moontheloon | |
10/4/2024 10:04 | No Board should have wasted £27million like this. The current CEO and Chairman and Board of directors are receiving top rate salaries and directors fees. They refuse to hold an investor meeting or any UK AGM where shareholders can raise their hand to vote. They refused to answer questions shortly after FDA approval and only repeated versions of the presentation and disabled questions on the day. It is long overdue that Mr Driehuys delivered his own university from research to clinical. This is no longer a research project | goldbutler | |
10/4/2024 10:03 | Polarean technology may be first class but UK investors responsible for financing it to this stage have had no return from it. The CEO only refers to two shareholder groups. Why have they left fund raise until now - are they running down the clock to the last two minutes- is it a shakedown. | goldbutler | |
10/4/2024 10:02 | Amaretto1 notice the common theme R Griffiths | john henry | |
10/4/2024 09:47 | This is isn't going that way believe me. Keep an eye on Recent links on LinkedIn things occurring .. think we are close to a European partner and part of the funding scenario. I've had dialogue with certain people in my research. Make of that what you will. Believe or not. I'm happy to hold and add. | moontheloon | |
10/4/2024 08:29 | ETX another de listing | amaretto1 | |
09/4/2024 14:57 | https://www.linkedin | moontheloon | |
08/4/2024 08:16 | Convert all trialists who have it already and love it... sometimes 2 times ;) in the next two years we have a profitable foundation. An high level de novo and one of the very top institutions in the u s came from nowhere... add these on top. Gas exchange on its way and a game changer and code enlargement for children. And potentially private health plans as these have started being put through as a precedence. I'm talking from a researched position.. parasites are exactly that, they just try to scare old grannies. Pathetic humans really. Sad. | moontheloon | |
08/4/2024 08:07 | Sure a few other isas etc will be being topped up in the coming week. | moontheloon | |
08/4/2024 08:05 | In for few more. Wink wink | moontheloon | |
08/4/2024 07:48 | They have 3 paid for sites functioning producing scans, target 5-7 2024. Two more. Duke is 100% in the bag I know I've researched deeply. Md Anderson top man stated also can't wait for it. Other triallists know its array of benefits and no radioactive improvements on traditional mri... as do Philips. Resulting in the great benefits for institutions and patients of being able to assess regular the state of the Lungs which radiation restricts. Go and find a company you like I would say. Thata a good fella | moontheloon | |
07/4/2024 17:56 | They need to generate a lot of revenue. I said back late last year time was ticking and they needed a lot of commercial traction early in 2024 - it hasn't happened. | nigelpm | |
07/4/2024 17:30 | Ummm.errrrr…Mo | purchaseatthetop | |
07/4/2024 16:42 | Doesn't matter whether it's listed or not - it's still pretty much game over. | nigelpm | |
07/4/2024 16:42 | Need a bug spray rns for the case of parasites we seem to have. Sp irrelevant when not selling | moontheloon | |
07/4/2024 16:40 | Gla lth. Plenty to come. Big rebound due. | moontheloon | |
07/4/2024 16:39 | Trying your sweet best now butler. I'll be honest it's way off and getting really boring now. Yawn. Find yourself a company you might actually buy shares in. You're boring holders here | moontheloon | |
07/4/2024 14:01 | It is curious GregB and DYMTurbo that theBoard of Directors has refused to do it. Amaretto1 has a word for it. It appears that the new CEO and Board are only interested in Bracco and Nukem They seek finance via AIM. They cannot bring themselves to refer to shareholders. The previous Chairman Mr Allis did On behalf of the Board, I thank the employees, stakeholders and shareholders for their support, without which none of this would have been possible. | goldbutler |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions